Abstract

e16504Background: The COU-AA-301 trial showed that abiraterone, an oral inhibitor of cytochrome p450 CYP17, improved survival in mCRPC patients progressing after docetaxel. Methods: Our first patie...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
Pawel Rajwa ... Shahrokh F. Shariat
The Journal of urology | VOL. 210
Pawel Rajwa, et. al.Pawel Rajwa ... Shahrokh F. Shariat
20 Jun 2023
Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
Cenk Y Bilen ... Ilker Kiliccioglu
Experimental biology and medicine (Maywood, N.J.) | VOL. 242
Cenk Y Bilen, et. al.Cenk Y Bilen ... Ilker Kiliccioglu
24 Aug 2017
Experience of a Brazilian oncological center using abiraterone acetate in metastatic castration-resistant prostate cancer patients.
Joao Antonio Junior Neif ... Carlos Alberto Fruet Filho
Journal of Clinical Oncology | VOL. 36
Joao Antonio Junior Neif, et. al.Joao Antonio Junior Neif ... Carlos Alberto Fruet Filho
20 Feb 2018
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
Ali Murat Sedef ... Ozan Cem Guler
Future oncology (London, England) | VOL. 15
Ali Murat Sedef, et. al.Ali Murat Sedef ... Ozan Cem Guler
12 Apr 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers